Pedro Vitor Lemos Cravo
AuthID: R-000-F3S
11
TITLE: Editorial letter
AUTHORS: Cravo, PVL; Silva, SDE;
PUBLISHED: 2018, SOURCE: Fronteiras, VOLUME: 7, ISSUE: 1
AUTHORS: Cravo, PVL; Silva, SDE;
PUBLISHED: 2018, SOURCE: Fronteiras, VOLUME: 7, ISSUE: 1
INDEXED IN: 
Scopus
Scopus12
TITLE: Editorial letter [Carta editorial]
AUTHORS: Cravo, PVL; Silva, SD;
PUBLISHED: 2017, SOURCE: Fronteiras, VOLUME: 6, ISSUE: 1
AUTHORS: Cravo, PVL; Silva, SD;
PUBLISHED: 2017, SOURCE: Fronteiras, VOLUME: 6, ISSUE: 1
INDEXED IN: Scopus
Scopus13
TITLE: Chalcone Derivatives: Promising Starting Points for Drug Design Full Text
AUTHORS: Marcelo N Gomes; Eugene N Muratov; Maristela Pereira; Josana C Peixoto; Lucimar P Rosseto; Pedro V L Cravo; Carolina H Andrade; Bruno J Neves;
PUBLISHED: 2017, SOURCE: MOLECULES, VOLUME: 22, ISSUE: 8
AUTHORS: Marcelo N Gomes; Eugene N Muratov; Maristela Pereira; Josana C Peixoto; Lucimar P Rosseto; Pedro V L Cravo; Carolina H Andrade; Bruno J Neves;
PUBLISHED: 2017, SOURCE: MOLECULES, VOLUME: 22, ISSUE: 8
INDEXED IN: Scopus 
WOS
Scopus WOS14
TITLE: Editorial Letter [Carta Editorial]
AUTHORS: Cravo, PVL; Dutra e Silva, S;
PUBLISHED: 2017, SOURCE: Fronteiras, VOLUME: 6, ISSUE: 4
AUTHORS: Cravo, PVL; Dutra e Silva, S;
PUBLISHED: 2017, SOURCE: Fronteiras, VOLUME: 6, ISSUE: 4
INDEXED IN: Scopus
Scopus15
TITLE: Modern approaches to accelerate discovery of new antischistosomal drugs
AUTHORS: Bruno Junior Neves; Eugene Muratov; Renato Beilner Machado; Carolina Horta Andrade; Pedro Vitor L Lemos Cravo;
PUBLISHED: 2016, SOURCE: EXPERT OPINION ON DRUG DISCOVERY, VOLUME: 11, ISSUE: 6
AUTHORS: Bruno Junior Neves; Eugene Muratov; Renato Beilner Machado; Carolina Horta Andrade; Pedro Vitor L Lemos Cravo;
PUBLISHED: 2016, SOURCE: EXPERT OPINION ON DRUG DISCOVERY, VOLUME: 11, ISSUE: 6
INDEXED IN: WOS 
CrossRef
WOS CrossRef16
TITLE: Carta editorial
AUTHORS: Cravo, PVL; Silva, SDE;
PUBLISHED: 2016, SOURCE: Fronteiras, VOLUME: 5, ISSUE: 1
AUTHORS: Cravo, PVL; Silva, SDE;
PUBLISHED: 2016, SOURCE: Fronteiras, VOLUME: 5, ISSUE: 1
INDEXED IN: Scopus CrossRef
Scopus CrossRef17
TITLE: In Silico Repositioning-Chemogenomics Strategy Identifies New Drugs with Potential Activity against Multiple Life Stages of Schistosoma mansoni Full Text
AUTHORS: Bruno J Neves; Rodolpho C Braga; Jose C B Bezerra; Pedro V L Cravo; Carolina H Andrade;
PUBLISHED: 2015, SOURCE: PLOS NEGLECTED TROPICAL DISEASES, VOLUME: 9, ISSUE: 1
AUTHORS: Bruno J Neves; Rodolpho C Braga; Jose C B Bezerra; Pedro V L Cravo; Carolina H Andrade;
PUBLISHED: 2015, SOURCE: PLOS NEGLECTED TROPICAL DISEASES, VOLUME: 9, ISSUE: 1
18
TITLE: How genomics is contributing to the fight against artemisinin-resistant malaria parasites Full Text
AUTHORS: Pedro Cravo; Hamilton Napolitano; Richard Culleton;
PUBLISHED: 2015, SOURCE: ACTA TROPICA, VOLUME: 148
AUTHORS: Pedro Cravo; Hamilton Napolitano; Richard Culleton;
PUBLISHED: 2015, SOURCE: ACTA TROPICA, VOLUME: 148
19
TITLE: Artemisinin resistance in rodent malaria - mutation in the AP2 adaptor mu-chain suggests involvement of endocytosis and membrane protein trafficking Full Text
AUTHORS: Gisela Henriques; Axel Martinelli; Louise Rodrigues; Katarzyna Modrzynska; Richard Fawcett; Douglas R Houston; Sofia T Borges; Umberto d'Alessandro; Halidou Tinto; Corine Karema; Paul Hunt; Pedro Cravo;
PUBLISHED: 2013, SOURCE: MALARIA JOURNAL, VOLUME: 12, ISSUE: 1
AUTHORS: Gisela Henriques; Axel Martinelli; Louise Rodrigues; Katarzyna Modrzynska; Richard Fawcett; Douglas R Houston; Sofia T Borges; Umberto d'Alessandro; Halidou Tinto; Corine Karema; Paul Hunt; Pedro Cravo;
PUBLISHED: 2013, SOURCE: MALARIA JOURNAL, VOLUME: 12, ISSUE: 1
20
TITLE: A Systematic In Silico Search for Target Similarity Identifies Several Approved Drugs with Potential Activity against the Plasmodium falciparum Apicoplast Full Text
AUTHORS: Nadlla Alves Bispo; Richard Culleton; Lourival Almeida Silva; Pedro Cravo;
PUBLISHED: 2013, SOURCE: PLOS ONE, VOLUME: 8, ISSUE: 3
AUTHORS: Nadlla Alves Bispo; Richard Culleton; Lourival Almeida Silva; Pedro Cravo;
PUBLISHED: 2013, SOURCE: PLOS ONE, VOLUME: 8, ISSUE: 3
